Relationship between in-hospital bacterial resistance and antimicrobial use over a 13-year period;Relación entre la resistencia bacteriana intrahospitalaria y el consumo de antimicrobianos durante un período de 13 años

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue 8, 2009, Pages 441-448

  Maortua, Hiart ^a   Canut, Andrés ^a   Ibáñez, Berta ^b   Martínez, Dolores ^a   De Domingo, Ma Jesús ^a   Labora, Alicia ^a  

^a HOSPITAL TXAGORRITXU   (Spain)

^b Fundación Vasca de Innovación e Investigación Sanitarias   (Spain)

Author keywords

Antimicrobial resistance; Antimicrobial use; Nosocomial infection; Regression analysis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DRUG USE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HOSPITALS; HUMANS; TIME FACTORS;

EID: 70349464384     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2008.09.017     Document Type: Article

References (52)

1. A.A. Muller, F. Mauny, M. Bertin, C. Cornette, J.M. López-Lozano, and J.F. Viel et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in French University Hospital Clin Infect Dis 36 2003 971 978
2. D.L. Monnet, F.M. MacKenzie, J.M. López-Lozano, A. Beyaert, M. Camacho, and R. Wilson et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000 Emerg Infect Dis 10 2004 1432 1441
3. A. Muller, J.M. López-Lozano, X. Bertrand, and D. Talor Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae J Antimicrob Chemother 54 2004 173 177
4. R.E. Polk, C.K. Johnson, D. McClish, R.P. Wenzel, and M.B. Edmond Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities Clin Infect Dis 39 2004 497 503
5. P. Kopterides, P.K. Koletsi, A. Michalopoulos, and M.E. Fagalas Exposure to quinolone is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates Int J Antimicrob Agents 30 2007 409 414
6. R.P. Wenzel, D.F. Sahm, C. Thornsberry, D.C. Draghi, M.E. Jones, and J.A. Karlowsky In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: Implications for therapy Antimicrob Agents Chemother 47 2003 3089 3098
7. A. Asensio, R. Cantón, J. Vaqué, J. Rosselló, and J.L. Arribas Antimicrobial use in Spanish hospitals (EPINE, 1990-1999) Med Clin 118 2002 731 736
8. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Estudio de Prevalencia de las Infecciones Nosocomiales en España: EPINE 2006 [consultado18/3/2008]. Disponible en: http://www.vhebron.es/ac/ preventiva/epine/5-epine-2006-espana.pdf
9. Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (GTEI-SEMICYUC). Estudio nacional de vigilancia de infección nosocomial en servicios de medicina intensiva. ENVIN-UCI: Informe 2006 [consultado18/3/ 2008]. Disponible en: http://hws.vhebron.net/envin-helics/Help/ENVIN-UCI%2706. pdf
10. World Health Organization (WHO). Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health: Oslo; 2005 [consultado 1/7/2008]. Disponible en: http://www.whocc.no/atcddd/
11. J.F. Hindler, and J. Stelling Analysis and presentation of cumulative antibiograms: A new consensus guideline from the Clinical and Laboratory Standards Institute (CLSI) Clin Infect Dis 44 2007 867 873
12. L.V. Friedrich, R.L. White, and J.A. Bosso Impact of use of multiple antimicrobial on changes in susceptibility of gram-negative aerobes Clin Infect Dis 28 1999 1017 1024
13. J. Vlcek, P. Sleszarova, E. Pozlerova, J. Kotlar, V. Blaha, and J. Mashburn The antibiotic resistance survey: A preliminary report on the drug utilization evaluation study at the university teaching hospital, Charles University, Czech Republic Pharmacoepidemiology and Drug Safety 9 2000 237 243
14. F.M. MacKenzie, D.L. Monnet, I.M. Gould on behalf of the ARPAC Steering Group Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals J Antimicrob Chemother 58 2006 657 660
15. R.A. Kiivet, M.L. Dahl, A. Llerena, M. Maiments, B. Wettermark, and R. Berecz Antibiotic use in 3 European university hospitals Scand J Infect Dis 30 1998 277 280
16. I.S. Petersen, L. Hesselbjerg, L. Jørgensen, J. Rentrup, S. Barnung, and J. Schierbeck et al. High antibiotic consumption in Danish intensive care units? APMIS 107 1999 989 996
17. K. De With, J. Bergner, R. Bühner, F. Dörje, C. Gonnermann, and M. Haber et al. Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II) Int J Antimicrob Agents 24 2004 15 20
18. K. De With, M. Steib-Bauert, P. Straach, and W.V. Kern Is there significant regional variation in hospital antibiotic consumption in Germany? Infection 34 2006 274 277
19. J.F. Mohr, A. Jones, L. Ostrosky-Zeichner, A. Wanger, and G. Tillotson Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: An 8-year-experience: 1995-2002 Int J Antimicrob Agents 24 2004 346 351
20. G.T. Ray, R. Baxter, and G.N. DeLorence Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa Clin Infect Dis 42 2005 441 449
21. J.A. Bosso, and P.D. Mauldin Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 50 2006 2106 2112
22. A.M. Rogues, C. Dumartin, B. Amadéo, A.G. Venier, N. Marty, and P. Parneix et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals Infect Control Hosp Epidemiol 28 2007 1389 1395
23. C. MacDougall, S.E. Harpe, P. Powell, C.K. Johnson, M. Edmond, and R.E. Polk Pseudomonas aeruginosa, Staphylococcus aureus and fluoroquinolone use Emerg Infect Dis 11 2005 1197 1204
24. A. Mahamat, F.M. MacKenzie, K. Brooker, D.L. Monnet, J.P. Daures, and I.M. Gould Impact of infection control interventions and antibiotic use on hospital MRSA: A multivariate interrupted time-series analysis Int J Antimicrob Agents 30 2007 169 176
25. E. Tacconelli, G. De Angelis, M.A. Cataldo, E. Pozzi, and R. Cauda Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systemic review and meta-analysis J Antimicrob Chemother 61 2008 26 38
26. S.J. Dancer The effect of antibiotics on methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 61 2008 246 253
27. D.L. Paterson, L. Mulazimoglu, J.M. Casellas, W.C. Ko, H. Goossens, and A.V. Gottberg et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae Clin Infect Dis 30 2000 473 478
28. E. Lautenbach, J.B. Patel, W.B. Bilker, P.H. Edelstein, and N.O. Fishman Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes Clin Infect Dis 32 2001 1162 1171
29. P.R. Hsueh, W.H. Chen, and K.T. Luh Relationship between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan Inter J Antimicrob Agents 26 2005 463 472
30. L.R. Peterson Squeezing the antibiotic ballon: The impact of antimicrobial classes on emerging resistance Clin Microb Infect 11 2005 4 16
31. P. Kopterides, P.K. Koletsi, A. Michalopoulos, and M.E. Falagas Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates Inter J Antimicrob Agents 30 2007 409 414
32. S.J. Dancer The problem with cephalosporins J Antimicrob Chemother 48 2001 463 478
33. Paterson DL. "Collateral Damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004; 38 Suppl 4: 341-5.
34. S.K. Fridkin, J.R. Edwar, J.M. Courval, H. Hill, F.C. Tenover, and R. Lawton et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units Ann Intern Med 135 2001 175 183
35. M. Washio, T. Mizoue, T. Kajioka, T. Yoshimitsu, M. Okayama, and T. Hamada et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital Public Health 111 1997 187 190
36. D. Landman, J.M. Quale, D. Mayorga, A. Adedeji, K. Vangala, and J. Ravishankar et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned Arch Intern Med 162 2002 1515 1520
37. G. Saurina, J.M. Quale, V.M. Manikal, E. Oydna, and D. Landman Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns J Antimicrob Chemother 45 2000 895 898
38. A. Asensio, A. Oliver, P. González-Diego, F. Baquero, J.C. Pérez-Díaz, and P. Ros et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection Clin Infect Dis 30 2000 55 60
39. D.L. Paterson, W.C. Ko, A. Von Gottberg, S. Mohapatra, J.M. Casellas, and H. Goossens et al. International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial infections Ann Intern Med 140 2004 26 32
40. J.J. Rahal, C. Urban, D. Horn, K. Freeman, S. Segal-Maurer, and J. Maurer et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1998 1233 1237
41. C.D. Settle, M.H. Wilcox, W.N. Fawley, O.J. Corrado, and P.M. Hawkey Prospective study of the risk of Clostridium difficile diarrhoea in enderly patients following treatment with cefotaxime or piperacillin-tazobactam Aliment Pharmacol Ther 12 1998 1217 1223
42. D.M. Livermore, S. Mushtaq, D. James, N. Potz, R.A. Walker, and A. Charlett et al. In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles Inter J Antimicrob Agents 22 2003 14 27
43. Martínez-Martínez L. Asociación de BLEE con otros mecanismos de resistencia. Enferm Infecc Microbiol Clin. 2007; 25 Suppl 2: 38-47.
44. E.M. Graffunder, and R.A. Venecia Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials J Antimicrob Chemother 49 2002 999 1005
45. F.M. MacKenzie, J. Bruce, M.J. Struelens, H. Goossens, J. Mollison, I.M. Goul of behalf of the ARPAC Steering Group Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals Clin Microbiol Infect 13 2007 269 276
46. G.F. Weldhagen, L. Poirel, and P. Nordmann Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: Novel developments and clinical impact Antimicrob Agents Chemother 47 2003 2385 2392
47. G.F. Weldhagen Integrons and β-lactamases a novel perspective on resistance Inter J Antimicrob Agents 23 2004 556 562
48. C. Bantar, E. Vesco, C. Helf, F. Salamone, M. Krayesky, and H. Gómez et al. Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: Impact on sustained high rates of bacterial resistance Antimicrob Agents Chemother 48 2004 392 395
49. G. Petrikkos, A. Markogiannakis, J. Papapareskevas, G.L. Daikos, G. Stefanakos, and N.P. Zissis et al. Differences in the changes in resistance patterns to third and fourth-generation cephalosporins and piperacillin/ tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in Greek tertiary care hospital Inter J Antimicrob Agents 29 2007 34 38
50. U. Frank, E.M. Kleissle, F.D. Daschner, L. Leibovici, M. Paul, and S. Andreassen et al. Multicentre study of antimicrobial resistance and antibiotic consumption among 6,780 patients with bloodstream infections Eur J Clin Microbiol Infect Dis 25 2006 815 817
51. J.M. López-Lozano, D.L. Monnet, A. Yagüe, A. Burgos, N. Gonzalo, and P. Campillos et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis Inter J Antimicrob Agents 14 2000 21 31
52. H. Grundmann, S. Barewolff, A. Tami, M. Behnke, F. Schwab, and C. Geffers et al. How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33 2005 946 951